Discussing COVID-19 Vaccines in Private Facebook Groups
- Conditions
- COVID-19
- Interventions
- Behavioral: COVID-19 vaccine informationBehavioral: Gist messages on COVID-19 vaccination
- Registration Number
- NCT05422898
- Lead Sponsor
- George Washington University
- Brief Summary
As the COVID-19 pandemic persists, a sizable proportion of the U.S. population remains unvaccinated and at high risk of death and serious illness from COVID-19. Vaccine hesitancy, fueled by the proliferation of vaccine misinformation on social media, is one factor contributing to lack of vaccination. Current attempts to overcome vaccine misinformation focus on correcting or debunking falsehoods. Although debunking strategies are important components to any public health campaign, communications must also address rationales for vaccine hesitancy that vary among individuals and communities, and directly address the gist of their concerns in an empathetic, non-judgmental manner. We will conduct a randomized controlled trial to test the effectiveness of empathic, relationship-building interactions relative to standard provision of information on social media to address COVID-19 vaccine hesitancy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 508
- reside in the U.S.
- unvaccinated from COVID-19
- Use Facebook regularly (at least 1/day)
- age <18 years
- do not reside in the U.S.
- vaccinated from COVID-19
- do not use Facebook regularly (at least 1/day)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Information COVID-19 vaccine information Link to Facebook COVID-19 Information Center Gist Gist messages on COVID-19 vaccination Gist-based messages on COVID-19 vaccination and moderated group discussions in a private Facebook group
- Primary Outcome Measures
Name Time Method Engagement and satisfaction with the program 4 weeks Engagement includes participation in the Facebook group; satisfaction=self-rated overall satisfaction with the program (7-point scale)
- Secondary Outcome Measures
Name Time Method Change in COVID-19 vaccination intention 4 weeks Self-reported intention to get the COVID-19 vaccine (7-point scale)
Change in COVID-19 vaccine confidence 4 weeks Self-reported confidence in the COVID-19 vaccine (5-point scale)
Change in general vaccine confidence 4 weeks Self-reported confidence in vaccines (7-point scale)
Change in intention to encourage others to get the COVID-19 vaccine 4 weeks Self-reported intention to encourage others to get the COVID-19 vaccine (7-point scale)
Proportion of participants getting the COVID-19 vaccine 4 weeks self-reported vaccination status
Change in vaccine hesitancy 4 weeks Self-reported vaccine hesitancy (7-point scale
Trial Locations
- Locations (1)
George Washington University
🇺🇸Washington, District of Columbia, United States